THE COX-2 INHIBITOR ETORICOXIB DID NOT ALTER THE ANTI-PLATELET EFFECTS OF LOW-DOSE ASPIRIN IN HEALTHY VOLUNTEERS.

THE COX-2 INHIBITOR ETORICOXIB DID NOT ALTER THE ANTI-PLATELET EFFECTS OF LOW-DOSE ASPIRIN IN HEALTHY VOLUNTEERS. John Wagner;Walter Kraft;Joanne Burke;Peggy Wong;Melanie Gleave;Lynn Wildonger;David Ebel;Sandi Vanburen;Keith Gottesdiener;Scott Waldman;Howard Greenberg; Arthritis & Rheumatism